Kenneth I Vaden
Examiner (ID: 13623, Phone: (571)270-5824 , Office: P/1732 )
Most Active Art Unit | 1732 |
Art Unit(s) | 1793, 1732 |
Total Applications | 309 |
Issued Applications | 208 |
Pending Applications | 0 |
Abandoned Applications | 101 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 3995361
[patent_doc_number] => RE036420
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-11-30
[patent_title] => 'Percutaneous preparation of tulobuterol'
[patent_app_type] => 2
[patent_app_number] => 9/129996
[patent_app_country] => US
[patent_app_date] => 1998-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3092
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 172
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/RE/036/RE036420.pdf
[firstpage_image] =>[orig_patent_app_number] => 129996
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/129996 | Percutaneous preparation of tulobuterol | Aug 5, 1998 | Issued |
Array
(
[id] => 4003022
[patent_doc_number] => 05962013
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-10-05
[patent_title] => 'Monolithic matrix transdermal delivery system for administering molsidomine'
[patent_app_type] => 1
[patent_app_number] => 9/128909
[patent_app_country] => US
[patent_app_date] => 1998-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6983
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/962/05962013.pdf
[firstpage_image] =>[orig_patent_app_number] => 128909
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/128909 | Monolithic matrix transdermal delivery system for administering molsidomine | Aug 3, 1998 | Issued |
08/973617 | TRANSDERMAL FORMULATION COMPRISING ROPINIROLE | Jul 22, 1998 | Abandoned |
Array
(
[id] => 3935912
[patent_doc_number] => 05989590
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-11-23
[patent_title] => 'Oral delivery of discrete units'
[patent_app_type] => 1
[patent_app_number] => 9/100202
[patent_app_country] => US
[patent_app_date] => 1998-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 15
[patent_no_of_words] => 4726
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/989/05989590.pdf
[firstpage_image] =>[orig_patent_app_number] => 100202
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/100202 | Oral delivery of discrete units | Jun 18, 1998 | Issued |
Array
(
[id] => 3975182
[patent_doc_number] => 05904934
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-05-18
[patent_title] => 'Ruminal drug delivery device'
[patent_app_type] => 1
[patent_app_number] => 9/082196
[patent_app_country] => US
[patent_app_date] => 1998-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 5626
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/904/05904934.pdf
[firstpage_image] =>[orig_patent_app_number] => 082196
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/082196 | Ruminal drug delivery device | May 20, 1998 | Issued |
Array
(
[id] => 3958321
[patent_doc_number] => 05900250
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-05-04
[patent_title] => 'Monoglyceride/lactate ester permeation enhancer for oxybutnin'
[patent_app_type] => 1
[patent_app_number] => 9/070492
[patent_app_country] => US
[patent_app_date] => 1998-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 13
[patent_no_of_words] => 7898
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/900/05900250.pdf
[firstpage_image] =>[orig_patent_app_number] => 070492
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/070492 | Monoglyceride/lactate ester permeation enhancer for oxybutnin | Apr 29, 1998 | Issued |
Array
(
[id] => 3929125
[patent_doc_number] => 05972376
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-10-26
[patent_title] => 'Transdermal system of tacrine/selegilin-plaster'
[patent_app_type] => 1
[patent_app_number] => 9/043231
[patent_app_country] => US
[patent_app_date] => 1998-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2961
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/972/05972376.pdf
[firstpage_image] =>[orig_patent_app_number] => 043231
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/043231 | Transdermal system of tacrine/selegilin-plaster | Mar 11, 1998 | Issued |
Array
(
[id] => 4042616
[patent_doc_number] => 05968533
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-10-19
[patent_title] => 'Skin care compositions and methods'
[patent_app_type] => 1
[patent_app_number] => 9/020762
[patent_app_country] => US
[patent_app_date] => 1998-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 10
[patent_no_of_words] => 6542
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/968/05968533.pdf
[firstpage_image] =>[orig_patent_app_number] => 020762
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/020762 | Skin care compositions and methods | Feb 8, 1998 | Issued |
Array
(
[id] => 3987477
[patent_doc_number] => 05985311
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-11-16
[patent_title] => 'Transdermal hormone patch'
[patent_app_type] => 1
[patent_app_number] => 9/010534
[patent_app_country] => US
[patent_app_date] => 1998-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2729
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 128
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/985/05985311.pdf
[firstpage_image] =>[orig_patent_app_number] => 010534
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/010534 | Transdermal hormone patch | Jan 21, 1998 | Issued |
Array
(
[id] => 4047035
[patent_doc_number] => 05932240
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-08-03
[patent_title] => 'Multidose transdermal drug delivery system'
[patent_app_type] => 1
[patent_app_number] => 8/986370
[patent_app_country] => US
[patent_app_date] => 1997-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 5162
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 139
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/932/05932240.pdf
[firstpage_image] =>[orig_patent_app_number] => 986370
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/986370 | Multidose transdermal drug delivery system | Dec 7, 1997 | Issued |
Array
(
[id] => 3920964
[patent_doc_number] => 05952000
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-09-14
[patent_title] => 'Fatty acid esters of lactic acid salts as permeation enhancers'
[patent_app_type] => 1
[patent_app_number] => 8/959946
[patent_app_country] => US
[patent_app_date] => 1997-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9283
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 135
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/952/05952000.pdf
[firstpage_image] =>[orig_patent_app_number] => 959946
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/959946 | Fatty acid esters of lactic acid salts as permeation enhancers | Oct 28, 1997 | Issued |
Array
(
[id] => 4218653
[patent_doc_number] => 06010715
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-01-04
[patent_title] => 'Transdermal patch incorporating a polymer film incorporated with an active agent'
[patent_app_type] => 1
[patent_app_number] => 8/954861
[patent_app_country] => US
[patent_app_date] => 1997-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 15
[patent_no_of_words] => 17064
[patent_no_of_claims] => 74
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 281
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/010/06010715.pdf
[firstpage_image] =>[orig_patent_app_number] => 954861
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/954861 | Transdermal patch incorporating a polymer film incorporated with an active agent | Oct 20, 1997 | Issued |
Array
(
[id] => 3991999
[patent_doc_number] => 05922353
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-07-13
[patent_title] => 'Interlocking couplings for osmotic delivery devices'
[patent_app_type] => 1
[patent_app_number] => 8/947110
[patent_app_country] => US
[patent_app_date] => 1997-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 4008
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/922/05922353.pdf
[firstpage_image] =>[orig_patent_app_number] => 947110
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/947110 | Interlocking couplings for osmotic delivery devices | Oct 7, 1997 | Issued |
Array
(
[id] => 3768684
[patent_doc_number] => 05807571
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-09-15
[patent_title] => 'Transdermal therapeutic systems for administering indole serotonin agonists'
[patent_app_type] => 1
[patent_app_number] => 8/946658
[patent_app_country] => US
[patent_app_date] => 1997-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2517
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 122
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/807/05807571.pdf
[firstpage_image] =>[orig_patent_app_number] => 946658
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/946658 | Transdermal therapeutic systems for administering indole serotonin agonists | Oct 6, 1997 | Issued |
Array
(
[id] => 3970958
[patent_doc_number] => 05916587
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-06-29
[patent_title] => 'Transdermal delivery matrix for piroxicam'
[patent_app_type] => 1
[patent_app_number] => 8/943140
[patent_app_country] => US
[patent_app_date] => 1997-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 3
[patent_no_of_words] => 3698
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 151
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/916/05916587.pdf
[firstpage_image] =>[orig_patent_app_number] => 943140
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/943140 | Transdermal delivery matrix for piroxicam | Oct 2, 1997 | Issued |
Array
(
[id] => 3987361
[patent_doc_number] => 05985305
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-11-16
[patent_title] => 'Sustained delivery of an active agent using an implantable system'
[patent_app_type] => 1
[patent_app_number] => 8/943007
[patent_app_country] => US
[patent_app_date] => 1997-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 11
[patent_no_of_words] => 8040
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/985/05985305.pdf
[firstpage_image] =>[orig_patent_app_number] => 943007
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/943007 | Sustained delivery of an active agent using an implantable system | Oct 1, 1997 | Issued |
Array
(
[id] => 4042802
[patent_doc_number] => 05968547
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-10-19
[patent_title] => 'Method of providing sustained analgesia with buprenorphine'
[patent_app_type] => 1
[patent_app_number] => 8/939068
[patent_app_country] => US
[patent_app_date] => 1997-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 14
[patent_no_of_words] => 20511
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/968/05968547.pdf
[firstpage_image] =>[orig_patent_app_number] => 939068
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/939068 | Method of providing sustained analgesia with buprenorphine | Sep 28, 1997 | Issued |
Array
(
[id] => 3975120
[patent_doc_number] => 05904930
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-05-18
[patent_title] => 'Transdermal system in the form of a patch comprising a tamoxifen derivative'
[patent_app_type] => 1
[patent_app_number] => 8/924742
[patent_app_country] => US
[patent_app_date] => 1997-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2149
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/904/05904930.pdf
[firstpage_image] =>[orig_patent_app_number] => 924742
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/924742 | Transdermal system in the form of a patch comprising a tamoxifen derivative | Sep 4, 1997 | Issued |
08/918322 | USE OF BISMUTH-CONTAINING COMPOUNDS IN TOPICAL DOSAGE FORMS FOR TREATMENT OF CORNEAL AND DERMAL WOUNDS | Aug 25, 1997 | Abandoned |
Array
(
[id] => 3993839
[patent_doc_number] => 05858393
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-01-12
[patent_title] => 'Transdermal formulation'
[patent_app_type] => 1
[patent_app_number] => 8/918141
[patent_app_country] => US
[patent_app_date] => 1997-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4119
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/858/05858393.pdf
[firstpage_image] =>[orig_patent_app_number] => 918141
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/918141 | Transdermal formulation | Aug 24, 1997 | Issued |